Background Sedaghatian-type spondylometaphyseal dysplasia (SSMD) is a neonatal lethal form of spondylometaphyseal dysplasia characterised by severe metaphyseal chondrodysplasia with mild limb shortening, platyspondyly, cardiac conduction defects, and central nervous system abnormalities. As part of the FORGE Canada Consortium we studied two unrelated families to identify the genetic aetiology of this rare disease.
ABSTRACT Background Sedaghatian-type spondylometaphyseal dysplasia (SSMD) is a neonatal lethal form of spondylometaphyseal dysplasia characterised by severe metaphyseal chondrodysplasia with mild limb shortening, platyspondyly, cardiac conduction defects, and central nervous system abnormalities. As part of the FORGE Canada Consortium we studied two unrelated families to identify the genetic aetiology of this rare disease.
Methods and results
Whole exome sequencing of a child affected with SSMD and her unaffected parents identified two rare variants in GPX4. The first (c.587 +5G>A) was inherited from the mother, and the second (c.588-8_588-4del) was de novo (NM_001039848.1); both were predicted to impact splicing of GPX4. In vitro studies confirmed the mutations spliced out part of exon 4 and skipped exon 5, respectively, with both resulting in a frameshift and premature truncation of GPX4. Subsequently, a second child with SSMD was identified; although DNA from the child was not available, the two unaffected parents were found by Sanger sequencing to each carry the same heterozygous stop mutation in exon 3 of GPX4, c.381C>A, p.Tyr127* (NM_001039848.1). Conclusions Our identification of truncating mutations in GPX4 in two families affected with SSMD supports the pathogenic role of mutated GPX4 in this very rare disease. GPX4 is a member of the glutathione peroxidase family of antioxidant defence enzymes and protects cells against membrane lipid peroxidation. GPX4 is essential for early embryo development, regulating anti-oxidative and anti-apoptotic activities. Our findings highlight the importance of this enzyme in development of the cardiac, nervous, and skeletal systems.
Sedaghatian-type spondylometaphyseal dysplasia (SSMD; MIM 250220) is a rare lethal disorder characterised by severe metaphyseal chondrodysplasia with mild limb shortening, platyspondyly, delayed epiphyseal ossification, irregular iliac crests, and pulmonary haemorrhage.
1-6 Sedaghatian first described SSMD in 1980 in a male from a sibship of three affected siblings born to non-consanguineous Iranian parents; all died within the first days of life due to respiratory failure. 7 A total of 18 infants from 12 families have been reported with SSMD. 1 Infants with SSMD present with severe hypotonia and cardiorespiratory problems; most succumb in days due to respiratory failure, with the longest surviving infant living to 161 days of age. 8 Cardiac abnormalities include conduction defects, complete heart block, and structural anomalies. 1 4-10 Half of infants with SSMD are reported to have central nervous system (CNS) malformations consistent with abnormal neuronal migration, including agenesis of the corpus callosum, pronounced frontotemporal pachygyria, simplified gyral pattern, partial lissencephaly, and severe cerebellar hypoplasia. 1 3 6 8 9 It has been suggested that CNS anomalies may be even more common and a defining feature of SSMD, but are under-reported in some infants due to the use of cerebral ultrasonography instead of more sensitive cranial MRI. 1 Given the occurrence of consanguinity in some families with SSMD and the presence of affected siblings in a number of the remaining families, SSMD is believed to be inherited in an autosomal recessive manner. 1 We set out to identify the responsible gene by analysing two families as part of the FORGE Canada Consortium.
The affected female infant in family 1 was the third child born to a 27-year-old G3T2L2 Northern European (Caucasian) mother and her unrelated 28-year-old Iranian father. She was the product of an uncomplicated term pregnancy and delivery with a birth weight at the 90th centile and head circumference at the ∼75th centile. She had subtle craniofacial dysmorphism, a small thorax, and mild rhizomelia. Apgar scores were low (3 1 , 6 5 and 6 10 ) and she did not breathe spontaneously until 8 min of life. A poor suck and gag, a weak grasp, and episodic decorticate posturing were noted. Her subsequent clinical course was characterised by recurrent apnoeic episodes and progressively worsening cardiac arrhythmias. Electroencephalogram (EEG), video EEG, cranial ultrasound and somatosensory evoked potentials were normal. Brain MRI at 3 days of age (figure 1A) demonstrated a simplified gyral pattern, mild narrowing of the foramen magnum at the C2 level, and mild bilateral symmetric amorphous high T1 signal in the globus pallidi. An abdominal and pelvic ultrasound demonstrated normal female anatomy. A skeletal survey was notably abnormal, with flattened vertebral bodies, absence of coronal clefts, 11 thoracic vertebrae, six lumbar vertebra, squaring of the inferior scapulae, flat acetabular roofs, small iliac wings, irregular metaphyses, and cupping of all bones in the extremities with abnormal shortening and widening of the metacarpals and phalanges (figure 1B-F). Blood culture, complete blood count (CBC), electrolytes, liver function, renal function, ammonia, very long-chain fatty acids, phytanic acid, extensive newborn screening analyses, and chromosomal microarray were all unremarkable. The infant was diagnosed clinically with SSMD. Given her deteriorating clinical course and poor prognosis, treatment was changed to palliative medical care and she died peacefully at home at 18 days of age.
The affected male infant in family 2 was born to Turkish first cousin parents and presented with the characteristic skeletal features of SSMD, including increased intervertebral disc spaces, platyspondyly, metaphyseal dysplasia, flat acetabular roofs, decreased sacrosciatic notch, small hypoplastic iliac bones, lacy iliac crest, and shortening and cupping of short tubular bones. 1 Other features of SSMD included generalised severe hypotonia, insufficient respiratory effort, and congenital atrioventricular block. 1 A cranial MRI showed severe CNS anomalies including a simplified gyral pattern, hypogenesis of the corpus callosum, and cerebellar hypoplasia. Myoclonic seizures started at 5 days of age and he died at 4 months of age secondary to respiratory failure.
The two families were enrolled in the FORGE Canada Consortium, a collaborative project with the goal of identifying novel genes for rare childhood diseases. Institutional research ethics board approval was obtained (Children's Hospital of Eastern Ontario) and the families were enrolled with informed consent. DNA was extracted by standard protocols. DNA from family 1 (affected infant and her parents) was subjected to exome capture and high-throughput sequencing. Target enrichment was achieved using the Agilent SureSelect 50 Mb (V3) All Exon Kit and followed by sequencing (Illumina HiSeq 2000), generating >14 Gbp of 100 bp, paired-end reads per sample. Read alignment, variant calling and annotation were done as outlined for previous FORGE projects 11 with a pipeline based on BWA (Burrows-Wheeler Aligner), Picard, Annovar, and custom annotation scripts. Variants were compared to those previously seen in the 1000 genomes phase 1 dataset (April 2012 release), the 6500 exomes of the National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project (ESP, Seattle, Washington, USA, data downloaded 3 October 2012), as well as in approximately 1000 exomes previously sequenced at the McGill University and Genome Quebec Innovation Centre.
Given the presumed recessive mode of inheritance, deleterious homozygous or compound heterozygous rare variants were sought. No interesting rare homozygous variants (or homozygous or de novo large copy number variations) were detected in family 1; however, two genes with compound heterozygous mutations were identified. In the first instance, two rare IARS gene variants (c.3563T>C; p.M1188 T and c.904A>T; p. N302Y (NM_002161.4)) were ultimately discounted due to the lack of interspecies conservation of the affected amino acids and minor allele frequencies of 0.05% and 0.2%, respectively. In the second instance, two rare GPX4 variants were detected that were not found in our control exome dataset or the NHLBI ESP exomes. The two GPX4 variants identified in family 1 were confirmed and segregated using Sanger sequencing ( figure 2A) . The first variant, c.587+5G>A, which was also identified in the mother, changes a highly conserved nucleotide, while the second, c.588-8_588-4del, is a de novo 5-bp deletion upstream of the 3 0 splice acceptor site (NM_001039848.1); both are predicted to affect GPX4 splicing. Paternity was confirmed using single nucleotide polymorphisms (SNPs) from the exome dataset.
A skin biopsy obtained from the affected child from family 1 failed to grow. Failure or difficulties with fibroblast growth have been previously reported both for SSMD patients and mice with ablated GPX4. 4 12 Given the lack of a patient fibroblast cell line, the impact of both variants (c.587+5G>A and c.588-8_588-4del) on GPX4 splicing was assessed utilising a mini-gene system. Patient and control genomic DNA comprising GPX4 exons 3 to 6 was PCR amplified, sequenced, and cloned into the mammalian expression vector pcDNA3.1(+). After mutated and wild-type construct transfection into human embryonic kidney (HEK) cells, reverse transcriptase PCR (RT-PCR) was performed ( figure 2B) . Sequencing of the resultant product revealed appropriate exon 4-5-6 splicing for the control GPX4 mini-gene construct, while the c.587+5G>A variant resulted in the splicing out of part of exon 4. This missplicing was also confirmed by RT-PCR on RNA extracted from the mother's fibroblast cell line, which contains the same mutation (data not shown). The second de novo c.588-8_588-4del GPX4 variant resulted in skipping of exon 5. With both variants, exon skipping results in a shift of the reading frame predicted to cause premature truncation of the GPX4 protein ( figure 2C ). The rarity of the two GPX4 variants combined with their disruptive impact on splicing, and therefore the resulting protein, prompted further investigation of GPX4 as a candidate gene in a second family with SSMD. Given the severity and rarity of SSMD, we were only able to obtain DNA from first cousin Turkish parents whose infant had died of SSMD (family 2). Sanger sequencing of the GPX4 gene in the parents looking for shared deleterious GPX4 variants identified a heterozygous stop mutation in exon 3, c.381C>A, p.Tyr127* in both ( figure 2D ). SSMD was one of the few severe spondylodysplastic dysplasias for which the molecular basis remained unknown; however, our results demonstrate that truncating mutations in GPX4 are responsible for this rare disease.
The GPX4 gene encodes one of eight human glutathione peroxidases. Although all eight have peroxidase activity thought to protect the organism from oxidative damage, GPX4 is unique in that it alone is involved in arachidonate metabolism and eicosanoid biosynthesis. 13 14 Of even greater pathogenic importance, GPX4 has broader substrate specificity than the other family members and, in addition to the reduction of small hydrophobic peroxides such as H 2 O 2, it reduces more complex substrates such as phospholipids, cholesterol, and cholesterol ester hydroperoxides, even those incorporated into membranes or lipoproteins (reviewed in Brigelius-Flohe and Maiorino 15 ). This is of relevance given that lipid hydroperoxides can serve as activators of lipoxygenase and cyclooxygenase, participate in inflammation, and act as signalling molecules for apoptotic cell death and receptor mediated signal transduction at the cellular level. 16 Expression of the GPX4 gene during mouse development begins very early in the developing nervous system, starting in the neural tube and then expanding to the developing neuroepithelium of the brain. 17 GPX4 mRNA is also expressed during the formation of most organs and is highly expressed in the developing limb where it acts to restrict the areas of apoptosis. 18 19 The importance of Gpx4 during embryogenesis has been demonstrated by the failure of Gpx4 homozygous knockout mice to survive past early gestation. 20 21 Neuronal specific Gpx4 knockout mice were also lethal in the neonatal period. 22 Interestingly, GPX4 is the only member of the GPX family that is essential for early development. 20 21 The unique (among the GPX proteins) anti-lipid peroxidation function of GPX4, combined with the fact that it is the only GPX required for normal embryonic development, point towards excessive lipid peroxidation as a central pathogenic feature. In this regard, investigation of both the neuronal cell lines and mice lacking Gpx4 has demonstrated that loss of Gpx4 causes massive lipid peroxidation that triggers apoptosis via activation of the apoptosis-inducing-factor mediated cell death pathway in neural cells. 22 In summary, we have shown that recessive truncating mutations in the GPX4 gene are the cause of SSMD, a lethal form of spondylometaphyseal dysplasia. The congenital malformations present in infants with SSMD suggest the importance of lipid peroxidation inhibition in normal CNS, cardiac, and other system development. Additional studies will be instructive to delineate this putative dysregulation of lipid peroxidation in SSMD pathogenesis. 
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